Bionano Genomics, Inc.
BNGO
$3.65
-$0.05-1.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -35.63% | -85.81% | -81.20% | -75.42% | -70.44% |
| Total Receivables | -60.60% | -50.58% | -37.38% | -20.69% | 25.56% |
| Inventory | -51.18% | -51.42% | -45.81% | -39.99% | -40.85% |
| Prepaid Expenses | -41.37% | -36.15% | -26.45% | -5.11% | -30.79% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -55.00% | -66.20% | -- | -- | -- |
| Total Current Assets | -47.52% | -71.82% | -55.06% | -50.59% | -39.95% |
|
|
|||||
| Total Current Assets | -47.52% | -71.82% | -55.06% | -50.59% | -39.95% |
| Net Property, Plant & Equipment | -32.46% | -25.12% | -15.53% | 6.28% | 12.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -73.64% | -71.43% | -69.12% | -20.07% | -19.36% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -65.61% | -59.72% | -70.24% | 84.97% | 121.29% |
| Total Assets | -50.37% | -64.24% | -51.97% | -52.33% | -45.92% |
|
|
|||||
| Total Accounts Payable | -33.34% | -32.95% | -43.39% | -26.68% | -37.62% |
| Total Accrued Expenses | -53.79% | -29.82% | -55.03% | -43.74% | -24.76% |
| Short-term Debt | -55.16% | -70.83% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -24.81% | 33.51% | -9.87% | 4.88% | -2.30% |
| Total Finance Division Other Current Liabilities | -80.04% | -80.14% | -79.59% | -77.07% | -6.52% |
| Total Other Current Liabilities | -80.04% | -80.14% | -79.59% | -77.07% | -6.52% |
| Total Current Liabilities | -54.86% | -62.67% | -18.02% | 10.97% | 53.42% |
|
|
|||||
| Total Current Liabilities | -54.86% | -62.67% | -18.02% | 10.97% | 53.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -55.16% | -70.83% | -- | -- | -- |
| Capital Leases | -44.30% | -48.66% | -31.24% | -30.63% | -26.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -97.19% | -97.58% | -98.25% | -59.03% | -25.13% |
| Total Liabilities | -59.82% | -65.08% | -38.81% | -13.42% | 24.00% |
|
|
|||||
| Common Stock & APIC | 7.06% | 7.56% | 9.75% | 10.84% | 12.53% |
| Retained Earnings | -13.66% | -19.27% | -25.27% | -48.05% | -58.78% |
| Treasury Stock & Other | 187.50% | 17.39% | 1,749.46% | 99.03% | 97.59% |
| Total Common Equity | -41.78% | -63.21% | -58.93% | -62.59% | -64.24% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -41.78% | -63.21% | -58.93% | -62.59% | -64.24% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -41.78% | -63.21% | -58.93% | -62.59% | -64.24% |
|
|
|||||